v3 Template
C

Codagenix Inc.

Biotechnology / Healthcare ~150 employees
Founded
--
Employees (Est.)
~150
10 leaders known
Total Funding
$25.0M
Funding Rounds
1
Last Funding
2023-02-15

About Codagenix Inc.

Codagenix, Inc. is a biotechnology company focused on engineering viruses to transform global health. They combine live-attenuated virus design with codon deoptimization technology to create a synthetic biology-based platform targeting major threats in infectious diseases.

Products & Services

Live Vaccines:Utilizing a synthetic biology-driven approach to design precise edits into viral genomes, delivering vaccines with broad immunity benefits, safety, speed, and scalability.

Specialties

Live-attenuated virus design Codon deoptimization technology Synthetic biology Infectious disease solutions

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B extension
T: -
FT: Series B extension 		A: 25000000
MR: -
FA: 25 million
FAN: 25000000 		D: 2023-02-15
FD: 2023-02-15 		3 investors
Series B extension Latest
2023-02-15
$25.0M
3 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

P

Paul Grint

Executive Chairman & Interim CEO

S

Steffen Mueller

Co-Founder, President & Chief Scientific Officer

J

Jeffrey Fu

Chief Business Officer

K

Kimber Poffenberger

Advisor, Strategy and Regulatory

T

Tyler Cook

Advisor, Finance

G

Gerard Cunningham

Operating Partner, Adjuvant Capital

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Codagenix Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~150 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro